Alkali Metals Ltd
Incorporated in 1968, Alkali Metals Ltd is a manufacturer of Sodium Derivatives, Pyridine Derivatives, Fine Chemicals and APIs etc.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Sales Volume of Finished Products MT ・Standalone data |
|
||||||||||
| Export Revenue Share of Total Turnover % ・Standalone data |
|||||||||||
| Number of Permanent Employees count ・Standalone data |
|||||||||||
| R&D Expenditure Rs Lakhs ・Standalone data |
|||||||||||
| Fine Chemicals Revenue Share % ・Standalone data |
|||||||||||
| Sodium Derivatives Revenue Share % ・Standalone data |
|||||||||||
| Top 5 Customer Concentration % ・Standalone data |
|||||||||||
| Overall Capacity Utilization % ・Standalone data |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Reg. 34 (1) Annual Report. 29 Jul
-
Notice Of The 58Th AGM
29 Jul - 58th AGM on 21 Aug 2026; dividend ₹1 per share proposed, director appointments and reappointments listed.
-
Disclosure under Regulation 30A of LODR
20 Jul - Alkali Metals appointed Sivarama Prasad Bhamidi as independent director for 5 years from 20 July 2026.
-
Board Meeting Outcome for Outcome Of The Board Meeting
20 Jul - Board approved Q1 FY27 unaudited results and appointed Sivarama Prasad Bhamidi as independent director from 20 July 2026.
-
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30Th June 2026
12 Jul - Board meets on 20 July 2026 to approve Q1 FY2027 unaudited results ended 30 June 2026.
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
Business Overview:[1]
AML, originally a joint venture with Andhra Pradesh Industrial Development Corporation Limited (APIDCL), is now an ISO 9001 & 14001-certified manufacturer specializing in sodium metal derivatives, picoline-based compounds, and cyclic chemicals. Its key products include sodium amide, sodium azide, sodium hydride, amino pyridines, fine chemicals, and APIs, primarily supplied to pharmaceutical companies for bulk drug production